Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Coleman

Showing results (291-300 of 510) with videos related to

Pageof 51
Sort By:
Open Forum Infectious Diseases|January 20, 2025
Association Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive AspergillosisBarbara D Alexander, Melissa Johnson, Mark Bresnik, et al.
Critical Care (London, England)|June 16, 2022
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysisOlivia S Costa, Stuart J Connolly, Mukul Sharma, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 21, 2020
Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort AnalysisOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
Genome Medicine|November 10, 2021
The genetic case for cardiorespiratory fitness as a clinical vital sign and the routine prescription of physical activity in healthcareKen B Hanscombe, Elodie Persyn, Matthew Traylor, et al.
The American Journal of Medicine|May 6, 2019
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing HemodialysisCraig I Coleman, Reinhold Kreutz, Nitesh A Sood, et al.
Connecticut Medicine|August 6, 2015
Reduction of Cardiac Arrests: The Experience of a Novel Service Centric Medical Emergency TeamAdam M Noyes, Jason A Gluck, Daniel Madison, et al.
Cell Host & Microbe|December 19, 2012
Nuclear repositioning precedes promoter accessibility and is linked to the switching frequency of a Plasmodium falciparum invasion geneBradley I Coleman, Ulf Ribacke, Micah Manary, et al.
Journal of Market Access & Health Policy|April 15, 2020
Specialist physician perspectives on non-medical switching of prescription medicationsOlivia S Costa, Tabassum Salam, Amy Duhig, et al.
BMC Genomics|June 3, 2014
Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondiiAndrew Farrell, Bradley I Coleman, Brian Benenati, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Pageof 51

Showing results (291-300 of 510) with videos related to

Sort By:
Pageof 51
Open Forum Infectious Diseases|January 20, 2025
Association Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive AspergillosisBarbara D Alexander, Melissa Johnson, Mark Bresnik, et al.
Critical Care (London, England)|June 16, 2022
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysisOlivia S Costa, Stuart J Connolly, Mukul Sharma, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 21, 2020
Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort AnalysisOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
Genome Medicine|November 10, 2021
The genetic case for cardiorespiratory fitness as a clinical vital sign and the routine prescription of physical activity in healthcareKen B Hanscombe, Elodie Persyn, Matthew Traylor, et al.
The American Journal of Medicine|May 6, 2019
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing HemodialysisCraig I Coleman, Reinhold Kreutz, Nitesh A Sood, et al.
Connecticut Medicine|August 6, 2015
Reduction of Cardiac Arrests: The Experience of a Novel Service Centric Medical Emergency TeamAdam M Noyes, Jason A Gluck, Daniel Madison, et al.
Cell Host & Microbe|December 19, 2012
Nuclear repositioning precedes promoter accessibility and is linked to the switching frequency of a Plasmodium falciparum invasion geneBradley I Coleman, Ulf Ribacke, Micah Manary, et al.
Journal of Market Access & Health Policy|April 15, 2020
Specialist physician perspectives on non-medical switching of prescription medicationsOlivia S Costa, Tabassum Salam, Amy Duhig, et al.
BMC Genomics|June 3, 2014
Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondiiAndrew Farrell, Bradley I Coleman, Brian Benenati, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Pageof 51